Tiziana Life Sciences is showcasing its ongoing Phase 2a BANYAN Clinical Trial investigating intranasal foralumab, a fully human anti-CD3 monoclonal antibody, at ALS Nexus 2026. The presentation highlights the potential impact of innovative immunomodulation therapies in addressing ALS.

Virax has announced a live investor webinar led by CEO James Foster. The conversation will cover the company’s financial outlook, a commercial plan for ImmuneSelect, and emerging developments for ViraxImmuneTM.

AC Immune has announced positive early findings from its Phase 1 study of a new NLRP3 inhibitor, known as ACI-19764. While further details remain behind a paywall, the initial results signal hopeful progress for this experimental approach.

A major shift in pharmaceutical research is unfolding as Cognizant prepares to introduce and implement Benchling’s AI platform at Kyowa Kirin’s Tokyo and Fuji Research Parks. This partnership aims to integrate data management, advanced automation, and AI-driven workflows to overhaul traditional research processes.

Kyowa Kirin’s new partnership with Cognizant and Benchling aims to accelerate research and development. By integrating data management, advanced automation, and AI-driven workflows, the collaboration seeks to reshape the company’s entire research lifecycle.

SunScout has arrived on the NYSE, setting its sights on the high-growth global robotic mower market, currently valued at $4.7 billion. While most specifics remain behind a paywall, this entry signals a bold step for SunScout’s future.

Researchers everywhere can expect more reliable product references and faster citation tracking. This partnership between Bioz, Inc. and Athens Bioscience promises a seamless, publication-driven validation framework to support life science innovations.

Taysha Gene Therapies completed patient dosing in two of its key Rett syndrome trials, marking critical progress toward a potential new gene therapy. With second quarter 2026 financial results reinforcing its commitment, the company aims to share top-line data and pursue FDA milestones in the year ahead.

The Lawton Public Library is calling on the community to donate LEGOs, Technic bricks, motors, and minifigures to support its robotics programs. This effort aims to equip local youth with hands-on learning opportunities, bridging fun and education one brick at a time.

ADMA Biologics reports $124.4 million in second-quarter revenue for 2026—a 2% increase year-over-year—and offers a brief business update. These figures point to modest yet steady growth in the current economic climate.

Agios Pharmaceuticals has released an update on its Phase 2 trial of tebapivat, a potential therapy for sickle cell disease. The announcement underscores ongoing efforts to address this rare disease and bring new options to those affected.

Pasithea Therapeutics will reveal new data on its macrocyclic MEK inhibitor, PAS-004, at the European Society for Medical Oncology (ESMO) Congress in 2026. The presentation promises insight into therapies targeting the MAPK pathway for advanced solid tumors.

Neuronata-R, a stem cell therapy, has retained its conditional approval from South Korea’s Ministry of Food and Drug Safety (MFDS) through May 2026. As its developer plans to resume supply, the path forward also includes establishing a U.S. research base.

Biotech stocks in 2026 revealed important trends when viewed through the BioWorld Stock Indicator and Nasdaq Biotech Index. This analysis compares the sector’s performance throughout the year, showcasing areas of growth and fluctuation.

Scientists at UM are taking a close look at the highest-dwelling mammal on Earth—a mouse that flourishes in minimal oxygen. Their findings may provide fresh insights into better drug and chemotherapy treatments for cancer patients worldwide.

An automated feed truck is taking center stage at the UNL research farm, delivering precise amounts of feed to cattle in any weather. Researchers aim to streamline daily operations and optimize feed distribution for thousands of livestock.

Vadzo Imaging’s Falcon-821CRS turbocharges autonomous mobile robots with 4K HDR imaging, an 8MP resolution, and a built-in 9-axis IMU. Designed to enhance real-time navigation and object detection, this camera targets warehouse and logistics automation around the globe.

Venti Technologies has entered a long-term agreement with a major North American intermodal railroad to deploy AI-powered autonomous vehicles. This pioneering initiative aims to curb costs and enhance safety while marking the first full-production use of autonomous container trucks in a large U.S. intermodal facility.

Addex has unveiled new research pointing to the crucial role of mGlu7 modulation in the control of sleep and wakefulness. Though details are limited, this announcement could mark a significant milestone for potential future therapies targeting sleep problems.

Genentech, a member of the Roche Group, is set to present new data from its Alzheimer’s disease portfolio at the Alzheimer’s Association International Conference® 2026 in London on July 12-15. These findings showcase the companies’ ongoing commitment to developing next-generation treatments and diagnostic tests aimed at slowing or stopping the progression of Alzheimer’s disease.

Dr. Guy German, Associate Professor and Graduate Program Director of Biomedical Engineering, stands at the forefront of scientific inquiry at the Thomas J. Watson College of Engineering and Applied Science. Photographed on June 4, 2025, in the Biotechnology Building, he exemplifies the innovative research shaping future breakthroughs.